Status:

COMPLETED

CCRC: Effects of Partially Hydrolyzed Whey Peptides (PHWP) On Weight Loss In Individuals With The Metabolic Syndrome (METS)

Lead Sponsor:

Sidika E. Karakas, MD

Collaborating Sponsors:

California Dairy Research Foundation

Conditions:

Metabolic Syndrome

Overweight

Eligibility:

All Genders

18-65 years

Phase:

NA

Brief Summary

The aim of this study is to compare the effects of two different protein supplements (partially hydrolyzed whey protein, PHWP vs. partially hydrolyzed gelatin, PHG) on weight loss in obse individuals ...

Detailed Description

The Metabolic Syndrome (METS) is a clinical disorder characterized by the following problems: Obesity, especially located in the waist area, elevated blood fats (lipids), high blood pressure and insul...

Eligibility Criteria

Inclusion

  • Clinical Diagnoses of Metabolic Syndrome (at least 3/5 of the following)
  • Waist Circumference: men: \>40 in women: \>35 in
  • Blood Pressure: \>135/\>85 mm Hg
  • Triglycerides: \>150 mg/dl
  • HDL-cholesterol: men: \<40 mg/dl women: \<50 mg/dl
  • Fasting Glucose: \>100 mg/dl
  • Ages 18 to 65 Years
  • BMI range of 27 to 42 kg/m\^2
  • Body weight \<300 lbs
  • Weight Stable for 3 Months

Exclusion

  • Subjects who habitually consume protein supplements or have eating disorders
  • Recent delivery (within 12 months), lactation, pregnancy or intention to become pregnant
  • Type 2 diabetes, kidney disease, liver disease, anemia, gout, cancer, untreated thyroid disease, gastrointestinal disease, other metabolic diseases or malabsorption syndromes
  • Triglyceride \>500 mg/dl, Cholesterol \>260 mg/dl
  • Use of insulin sensitizers, lipid lowering medication or ACE inhibitors
  • Use of anti-obesity medications or supplements for at lease 6 months prior to start of study
  • Known allergy or adverse reaction to protein and dairy products (including lactose)

Key Trial Info

Start Date :

August 1 2008

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

August 1 2010

Estimated Enrollment :

35 Patients enrolled

Trial Details

Trial ID

NCT00739479

Start Date

August 1 2008

End Date

August 1 2010

Last Update

October 29 2012

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

UC Davis CCRC

Sacramento, California, United States, 95616